US Researchers Start Clinical Trials To Test Mix-And-Match Covid Vaccine Boosters
Road To Atmanirbhar Bharat: Dr. Harsh Vardhan On India As A Healthcare Hub
Australia Abandons Efforts To Develop Homegrown Covid-19 Vaccine After Volunteers In Trials Develop Antibodies For HIV
Chennai Volunteer Claims Neurological Complications From Covid Test Vaccine, Serum Institute Says Symptoms Not Related To Vaccine Trials
UK’s Chief Scientific Adviser Patrick Vallance Faces Questions About Conflict Of Interest For Holding Shares in Pharma Giant GSK
Govt Plans To Issue E-Certificates To Vaccinated Individuals Once An Effective Vaccine Is Developed
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 Participants
Safe So Far: Bharat Biotech - ICMR's Covaxin Shows No Adverse Effects In Preliminary Phase I Results
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine
US Government Backed Moderna’s Coronavirus Vaccine Begins Phase 3 Final-Stage Testing, 30000 People To Be Dosed
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
Serum Institute To Start Human Trials For Oxford Vaccine In India From August
‘Positive News’ On Oxford Coronavirus Vaccine, Now Undergoing Phase III Human Trials, Likely To Come As Early As Today
Moderna Coronavirus Vaccine Induced Desired Immune Response In All 45 People Evaluated, Phase-3 Clinical Trial Soon
COVAXIN: India’s First Indigenous COVID-19 Vaccine Candidate To Begin Human Trials Next Week
US Green Signals Four Candidate COVID-19 Vaccines For Clinical Trials; Six More Under Review
First Volunteer Who Receives Imperial College’s RNA-based COVID-19 Vaccine In Good Health, Trials Enters Next Phase
Here Is A List Of Seven Organisations In The Race To Develop A Coronavirus Vaccine
Coronavirus Vaccine Developed By US Biotech Firm Moderna Produces COVID-19 Antibodies in All 45 Participants
Glenmark Pharma Begins Phase 3 Of Clinical Trials For Favipiravir, Potential COVID-19 Drug In India
ICMR, National Institute Of Virology Join Hands With Hyderabad Based Biotech Firm To Develop COVID-19 Vaccine
Italian Researchers Claim World’s First COVID-19 Vaccine That Can Stop Coronavirus From Infecting Human Cells
Oxford University Researchers Plan To Expand Testing Of Under-Trial Potential COVID-19 Vaccine
High-Level Task Force Instituted To Converge Efforts Towards Vaccine And Drug Testing To Fight COVID-19
Two Potential Coronavirus Vaccines Approved For Clinical Trials in China; Capable Of Large Scale Vaccination
Bill Gates Announces Multi-Billion Funding For Developing 7 Potential Coronavirus Vaccines
BCG Vaccine’s Potential To Fight Coronavirus, Explained By India’s Top Immunologist
India Fights Back: Top Scientist Team At NII Working Round The Clock To Develop Covid-19 Vaccine
